Watch VYCO. Know when insiders buy.
One email the day a filing lands. Free.
VYCO
VYCOR MEDICAL INC
0.07
+0.00 +0.00%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.2MP/E —DIV YIELD —FCF YIELD —REV TTM $1.8M +1.6%NET INCOME −$60KNET DEBT $1.9M52W 0.05 – 0.20SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $418K | −15.7% | 82.4% | $7K | −$22K | −193.3% | 0.00 | −$5K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $459K | +5.1% | 81.8% | $46K | $20K | — | 0.00 | $99K | — | — | May 15 |
| Q4 2025 · Dec 31derived | $417K | −8.4% | 80.4% | −$37K | −$63K | — | 0.00 | $39K | $2K | $38K | Mar 31 |
| Q3 2025 · Sep 30 | $514K | +31.5% | 88.0% | $32K | $5K | — | 0.00 | −$72K | $1 | −$72K | Nov 14 |
| Q2 2025 · Jun 30 | $496K | +22.2% | 83.7% | $51K | $24K | — | 0.00 | $47K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $436K | +29.5% | 82.2% | −$13K | −$39K | — | -0.01 | −$27K | — | — | May 15 |
| Q4 2024 · Dec 31derived | $455K | +47.7% | 87.3% | $19K | −$7K | — | 0.00 | −$38K | −$2 | −$38K | Mar 31 |
| Q3 2024 · Sep 30 | $391K | +26.7% | 90.6% | −$35K | −$60K | — | -0.01 | $10K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | $406K | — | 91.3% | $16K | −$10K | — | 0.00 | $86K | — | — | Aug 8 |
| Q1 2024 · Mar 31 | $337K | — | 89.0% | −$10K | −$31K | — | -0.01 | $2K | — | — | May 15 |
| Q4 2023 · Dec 31derived | $308K | — | 86.4% | −$64K | −$93K | — | 0.00 | $6K | $6K | −$396 | Apr 15 |
| Q3 2023 · Sep 30 | $309K | — | 89.5% | −$25K | −$52K | — | -0.01 | −$15K | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.9M | 83.8% | $34K | −$72K | -3.9% | -0.01 | −$13K | $5K | −$19K | — | — |
| FY2024 · to Dec 31 | $1.6M | 89.5% | −$9K | −$107K | -6.7% | -0.01 | $60K | $5K | $55K | — | — |
| FY2023 · to Dec 31 | $1.5M | 90.1% | $40K | −$70K | -4.8% | -0.01 | $29K | $9K | $20K | — | — |
| FY2022 · to Dec 31 | $1.2M | 88.5% | −$307K | −$405K | -33.1% | -0.02 | −$217K | $3K | −$220K | — | — |
| FY2021 · to Dec 31 | $1.4M | 90.3% | −$436K | −$436K | -31.3% | -0.03 | $21K | $38K | −$17K | — | — |
| FY2020 · to Dec 31 | $1.1M | 88.4% | −$727K | −$822K | -72.0% | -0.04 | −$249K | $62K | −$311K | — | — |
Every number comes from VYCOR MEDICAL INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.